查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370949

自體免疫疾病診斷市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品、測試類型、疾病類型、最終用戶、地區和競爭細分

Autoimmune Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Test Type, By Disease Type, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 189 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022年全球自體免疫疾病診斷市場估值為50.2億美元，預計在整個預測期內將呈現強勁成長，預計年複合成長率（CAGR）為6.37%，預計到2028年將達到72.8億美元。 ( AD) 是一種非傳染性疾病，其特徵是健康的免疫平衡被破壞，導致受影響的組織細胞出現異常反應。發炎、自體抗體和活化的 T 細胞在自體免疫疾病的發展中至關重要。雖然免疫細胞通常會辨識並對抗細菌和病毒等外部因素，但自體免疫疾病會導致免疫系統錯誤地攻擊身體本身。一些自體免疫疾病專門針對特定器官。全球存在近80種自體免疫疾病，包括系統性紅斑狼瘡和類風濕性關節炎。美國自體免疫相關疾病協會（AARDA）顯示，多達5,000萬美國人患有自體免疫疾病，其中女性佔75%。自體免疫疾病的診斷檢查包括自體抗體測試、抗核抗體測試、全血球計數、C反應蛋白和紅血球沉降速率。

主要市場促進因素

對自體免疫疾病的認知不斷增強

市場概況
預測期 2024-2028
2022 年市場規模 50.2億美元
2028 年市場規模 72.8億美元
2023-2028 年年複合成長率 6.37%
成長最快的細分市場 類風濕性關節炎
最大的市場 北美洲

壓力、基因突變、不健康的飲食習慣和環境因素對自體免疫疾病的發展有顯著影響。自體免疫疾病的全球流行導致對自體免疫疾病診斷的需求增加。例如，2020 年CDC 國家糖尿病統計報告指出，大約有140 萬美國人患有1 型糖尿病，預計到2040 年這一數字將增加到210 萬。公共和私人組織提高認知的努力有助於增加對自身免疫性疾病的了解。自體免疫協會（美國）等組織進行宣傳活動，傳播有關這些疾病的訊息。早期自體免疫疾病診斷對於最大限度地減少殘疾、發病率和死亡率至關重要，從而推動自體免疫疾病診斷市場的成長。

自體免疫疾病的發生率增加

發炎性腸道疾病（IBD）和類風濕性關節炎等自體免疫疾病的盛行率不斷上升，預計將對自體免疫疾病診斷市場產生重大影響。隨著越來越多的人受到影響，人們更加重視早期發現和診斷。這種及時的診斷對於啟動適當的治療和管理策略至關重要。不同自體免疫疾病的發生率較高，需要進行多種診斷測試來準確區分這些疾病。這些發展促進了對綜合診斷工具包的需求，以解決不同的疾病表現。

診斷技術的改進

技術進步使得多種自身抗體的同時辨識和測量成為可能。抗原微陣列和質譜等技術提高了檢測與自體免疫疾病相關的特異性抗體或生物標記的敏感度。這些進步可以實現更精確和早期的檢測。實驗室自動化和傳統技術的替代有助於擴大全球自體免疫疾病診斷市場。

主要市場挑戰

需要多次診斷測試和延長週轉時間

檢測自體免疫疾病非常耗時，涉及各種測試場景，例如類風濕性關節炎、艾迪生氏病和橋本氏病的血清檢測。由於沒有單一的測試能夠可靠地、高精度地檢測特定的自體免疫疾病，因此需要進行多項實驗室測試。這些測試可能包括完整的代謝檢查、血球計數報告、血清學、流式細胞儀和 HLA 分型。這些測試的周轉時間可能會延長，妨礙及時診斷。此外，高昂的測試成本和報銷問題也是挑戰。缺乏熟練的專業人員也會影響市場。

發展中地區的滲透率有限

儘管自體免疫疾病的盛行率不斷上升，但有限的產品滲透率限制了市場擴張。發展中市場缺乏針對發炎性腸道疾病等新興疾病的監測和資料庫。流行病學資料和有效診斷的途徑有限。缺乏意識阻礙了任命，阻礙了新興國家的市場成長。

主要市場趨勢

創新的自體免疫疾病檢測方法

對準確診斷的需求催生了競爭格局，並鼓勵了新參與者。鼓勵老牌領導者之間的競爭性定價，亞太地區由於尚未開發的成長和不斷擴大的患者人數而提供了潛力。研究提供了收入機會，而意識努力為獨特診斷技術的發展創造了空間。自動化和傳統技術替代有助於市場擴張。

現場護理和家庭檢測

對方便、快速診斷的需求可能會推動現場護理和家庭檢測套件的開發。患者可以方便地監測自己的病情，幫助更快做出治療決定。家庭測試減輕了醫療機構的負擔，使患者在醫療保健中發揮更積極的作用。

細分市場洞察

疾病類型

由於手術量大和患者意識相對較高，局部疾病診斷在市場上佔據主導地位。在政府積極措施和意識提高的推動下，系統性疾病診斷預計將快速成長。

產品

由於已開發國家的高診斷率和經常性購買的推動，預計到 2023 年，試劑、檢測方法和試劑盒領域將佔據最大的市場佔有率。

區域洞察

亞太

由於自體免疫疾病盛行率增加、不健康的生活方式、政府措施和研究投資，亞太地區有望實現高速成長。印度的牛皮癬病例預計將增加，導致該地區患病率不斷上升。

結論

由於意識的提高、自體免疫疾病發病率的增加、診斷的改進和創新方法，全球自體免疫疾病診斷市場正在經歷成長。挑戰包括需要進行多次測試、延長週轉時間、在發展中地區的滲透率有限以及缺乏熟練的專業人員。趨勢包括創新的檢測方法和現場護理/家庭檢測。疾病類型、產品和區域因​​素正在影響市場動態。由於自體免疫疾病盛行率不斷擴大，亞太地區具有潛力。總體而言，自體免疫疾病診斷市場將會成長，重點是早期診斷和改進的測試技術。

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球自體免疫疾病診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 副產物（試劑、試劑盒、測定、儀器）
    • 依測試類型（抗核抗體測試、自體抗體測試、C 反應蛋白、全血球計數、尿液分析）
    • 依疾病類型（全身性、局部性）
    • 透過最終使用者（醫院、診斷實驗室、研究機構），
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章：北美自體免疫疾病診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按測試類型
    • 依疾病類型
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲自體免疫疾病診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按測試類型
    • 依疾病類型
    • 按最終用戶
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區自體免疫疾病診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按測試類型
    • 依疾病類型
    • 按最終用戶
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲自體免疫疾病診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按測試類型
    • 依疾病類型
    • 按最終用戶
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲自體免疫疾病診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按測試類型
    • 依疾病類型
    • 按最終用戶
  • MEA：國家分析
    • 南非自體免疫疾病診斷
    • 沙烏地阿拉伯自體免疫疾病診斷
    • 阿拉伯聯合大公國自體免疫疾病診斷

第 11 章：市場動態

第 12 章：市場趨勢與發展

第 13 章：全球自體免疫疾病診斷市場：SWOT 分析

第14章：競爭格局

  • 商業概覽
  • 服務產品
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Siemens Healthcare Private Limited
    • bioMerieux SA
    • Bio-rad Laboratories
    • Beckman Coulter, Inc.
    • F. Hoffmann-la Roche
    • Inova Diagnostics, Inc.
    • Myriad Genetics, Inc.
    • Thermo Fisher Scientific
    • Trinity Biotech Plc.
    • Hemagen Diagnostics, Inc.

第 15 章：策略建議

第 16 章：關於我們與免責聲明

簡介目錄
Product Code: 4544

The Global Autoimmune Disease Diagnostics Market was valued at USD 5.02 Billion in 2022 and is expected to exhibit strong growth throughout the forecast period, projecting a Compound Annual Growth Rate (CAGR) of 6.37% and expected to reach USD 7.28 Billion through 2028. Autoimmune disease (AD) is a non-communicable ailment characterized by the disruption of healthy immunological equilibrium, leading to aberrant reactions in affected tissue cells. Inflammation, autoantibodies, and activated T cells are pivotal in the development of autoimmune disorders. While immune cells typically recognize and combat external agents like bacteria and viruses, autoimmune diseases lead to the immune system erroneously attacking the body itself. Some autoimmune conditions specifically target particular organs. Globally, almost 80 types of autoimmune diseases exist, including systemic lupus erythematosus and rheumatoid arthritis. The American Autoimmune Related Diseases Association (AARDA) reveals that up to 50 million Americans suffer from autoimmune diseases, with females constituting 75% of the cases. Diagnostic tests for autoimmune diseases encompass autoantibody tests, antinuclear antibody tests, complete blood count, C-reactive protein, and erythrocyte sedimentation rate.

Key Market Drivers

Growing Awareness of Autoimmune Diseases

Market Overview
Forecast Period2024-2028
Market Size 2022USD 5.02 Billion
Market Size 2028USD 7.28 Billion
CAGR 2023-20286.37%
Fastest Growing SegmentRheumatoid Athritis
Largest MarketNorth America

Stress, genetic mutations, unhealthy eating habits, and environmental factors contribute significantly to autoimmune disease development. The global prevalence of autoimmune diseases has led to an increased demand for autoimmune disease diagnostics. For instance, the 2020 CDC National Diabetes Statistics Report states that approximately 1.4 million Americans have Type-1 diabetes, with projections indicating a rise to 2.1 million by 2040. Heightened awareness efforts by public and private organizations have contributed to increased knowledge of autoimmune diseases. Organizations like the Autoimmune Association (U.S.) conduct awareness campaigns to disseminate information about these disorders. Early autoimmune disease diagnosis is pivotal in minimizing disability, morbidity, and mortality rates, driving the autoimmune disease diagnostics market's growth.

Increasing Incidence of Autoimmune Diseases

The increasing prevalence of autoimmune diseases, such as Inflammatory Bowel Disease (IBD) and rheumatoid arthritis, is expected to significantly impact the autoimmune disease diagnostics market. As more individuals are affected, there is a greater emphasis on early detection and diagnosis. This timely diagnosis is crucial for initiating appropriate treatment and management strategies. The higher incidence of different autoimmune diseases necessitates a diverse array of diagnostic tests that can accurately differentiate between these conditions. These developments contribute to the demand for a comprehensive diagnostic toolkit to address diverse disease presentations.

Improvement in Diagnostic Techniques

Technological advancements have enabled the simultaneous identification and measurement of multiple autoantibodies. Techniques like antigen microarrays and mass spectrometry offer increased sensitivity in detecting specific antibodies or biomarkers associated with autoimmune diseases. These advancements allow for more precise and early detection. Automation of laboratories and the replacement of conventional technologies contribute to the expansion of the global autoimmune disease diagnostics market.

Key Market Challenges

Need for Multiple Diagnostic Tests and Prolonged Turnaround Time

Detecting autoimmune diseases is time-consuming, involving various testing scenarios like serum testing for rheumatoid arthritis, Addison's disease, and Hashimoto's disease. Multiple laboratory tests are necessary due to no single test reliably detecting a specific autoimmune disease with high accuracy. These tests may include a complete metabolic panel, blood count report, serologies, flow cytometry, and HLA typing. Turnaround times for these tests can be extended, impeding prompt diagnosis. Moreover, high test costs and reimbursement issues are challenges. The lack of skilled professionals also impacts the market.

Limited Penetration in Developing Regions

While autoimmune diseases' prevalence is rising, limited product penetration restricts market expansion. Developing markets lack surveillance and databases for emerging diseases like IBD. Epidemiological data and access to efficient diagnostics are limited. Lack of awareness hampers appointments, impeding market growth in emerging countries.

Key Market Trends

Innovative Autoimmune Disease Detection Approaches

The demand for accurate diagnosis fosters a competitive landscape, encouraging new players. Competitive pricing among established leaders is encouraged, and the Asia-Pacific region offers potential due to untapped growth and an expanding patient population. Research studies present revenue opportunities, and awareness efforts create room for unique diagnostic techniques' development. Automation and conventional technology replacement contribute to market expansion.

Point-of-Care and Home Testing

Demand for convenient and rapid diagnostics could drive point-of-care and home testing kits' development. Patients can monitor their conditions conveniently, aiding quicker treatment decisions. Home testing reduces healthcare facility burden and allows patients to play a more active role in their healthcare.

Segmental Insights

Disease Type

Localized disease diagnostics dominated the market due to large procedure volumes and relatively higher patient awareness. Systemic disease diagnostics are projected to grow rapidly, fueled by favorable government initiatives and increased awareness.

Product

The reagents, assays, and kits segment is expected to hold the largest market share by 2023, driven by high diagnosis rates and recurring purchases in developed countries.

Regional Insights

Asia-Pacific

The Asia-Pacific region is poised for high growth due to increasing autoimmune disease prevalence, unhealthy lifestyles, government initiatives, and research investments. Psoriasis cases in India are projected to rise, contributing to the region's growing prevalence.

Conclusion

The Global Autoimmune Disease Diagnostics Market is experiencing growth due to rising awareness, increasing autoimmune disease incidence, diagnostic improvements, and innovative approaches. Challenges include the need for multiple tests, extended turnaround time, limited penetration in developing regions, and a shortage of skilled professionals. Trends include innovative detection methods and point-of-care/home testing. Disease type, product, and regional factors are influencing market dynamics. The Asia-Pacific region holds potential due to expanding autoimmune disease prevalence. Overall, the autoimmune disease diagnostics market is set to grow with a focus on early diagnosis and improved testing techniques.

Key Market Players

  • Siemens Healthcare Private Limited
  • bioMerieux SA
  • Bio-rad Laboratories
  • Beckman Coulter, Inc.
  • F. Hoffmann-la Roche
  • Inova Diagnostics, Inc.
  • Myriad Genetics, Inc.
  • Thermo Fisher Scientific
  • Trinity Biotech Plc.
  • Hemagen Diagnostics, Inc.

Report Scope:

In this report, the Global Autoimmune Disease Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Autoimmune Disease Diagnostics Market, By Product:

  • Reagents
  • Kits
  • Assays
  • Instruments

Autoimmune Disease Diagnostics Market, By Test Type:

  • Antinuclear Antibody Tests
  • Autoantibody Tests
  • C-reactive Protein
  • Complete Blood Count
  • Urinalysis

Autoimmune Disease Diagnostics Market, By Disease Type:

  • Systemic
  • Localized

Autoimmune Disease Diagnostics Market, By End User:

  • Hospitals
  • Diagnostic Labs
  • Research Institutes

Autoimmune Disease Diagnostics Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Autoimmune Disease Diagnostics Market.

Available Customizations:

  • Global Autoimmune Disease Diagnostics market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Autoimmune Disease Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Reagents, Kits, Assays, Instruments)
    • 5.2.2. By Test Type (Antinuclear Antibody Tests, Autoantibody Tests, C-reactive Protein, Complete Blood Count, Urinalysis)
    • 5.2.3. By Disease Type (Systemic, Localized)
    • 5.2.4. By End User (Hospitals, Diagnostic Labs, Research Institutes),
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Market Map

6. North America Autoimmune Disease Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Test Type
    • 6.2.3. By Disease Type
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Autoimmune Disease Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Test Type
        • 6.3.1.2.3. By Disease Type
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Autoimmune Disease Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Test Type
        • 6.3.2.2.3. By Disease Type
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Autoimmune Disease Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Test Type
        • 6.3.3.2.3. By Disease Type
        • 6.3.3.2.4. By End User

7. Europe Autoimmune Disease Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Test Type
    • 7.2.3. By Disease Type
    • 7.2.4. By End User
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Autoimmune Disease Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Test Type
        • 7.3.1.2.3. By Disease Type
        • 7.3.1.2.4. By End User
    • 7.3.2. United Kingdom Autoimmune Disease Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Test Type
        • 7.3.2.2.3. By Disease Type
        • 7.3.2.2.4. By End User
    • 7.3.3. Italy Autoimmune Disease Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Test Type
        • 7.3.3.2.3. By Disease Type
        • 7.3.3.2.4. By End User
    • 7.3.4. France Autoimmune Disease Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Test Type
        • 7.3.4.2.3. By Disease Type
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Autoimmune Disease Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Test Type
        • 7.3.5.2.3. By Disease Type
        • 7.3.5.2.4. By End User

8. Asia-Pacific Autoimmune Disease Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Test Type
    • 8.2.3. By Disease Type
    • 8.2.4. By End User
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Autoimmune Disease Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Test Type
        • 8.3.1.2.3. By Disease Type
        • 8.3.1.2.4. By End User
    • 8.3.2. India Autoimmune Disease Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Test Type
        • 8.3.2.2.3. By Disease Type
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Autoimmune Disease Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Test Type
        • 8.3.3.2.3. By Disease Type
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Autoimmune Disease Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Test Type
        • 8.3.4.2.3. By Disease Type
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Autoimmune Disease Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Test Type
        • 8.3.5.2.3. By Disease Type
        • 8.3.5.2.4. By End User

9. South America Autoimmune Disease Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Test Type
    • 9.2.3. By Disease Type
    • 9.2.4. By End User
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Autoimmune Disease Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Test Type
        • 9.3.1.2.3. By Disease Type
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Autoimmune Disease Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Test Type
        • 9.3.2.2.3. By Disease Type
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Autoimmune Disease Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Test Type
        • 9.3.3.2.3. By Disease Type
        • 9.3.3.2.4. By End User

10. Middle East and Africa Autoimmune Disease Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Test Type
    • 10.2.3. By Disease Type
    • 10.2.4. By End User
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Autoimmune Disease Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Test Type
        • 10.3.1.2.3. By Disease Type
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Autoimmune Disease Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Test Type
        • 10.3.2.2.3. By Disease Type
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Autoimmune Disease Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Test Type
        • 10.3.3.2.3. By Disease Type
        • 10.3.3.2.4. By End User

11. Market Dynamics

12. Market Trends & Developments

13. Global Autoimmune Disease Diagnostics Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Services Offerings
  • 14.3. Recent Developments
  • 14.4. Key Personnel
  • 14.5. SWOT Analysis
    • 14.5.1. Siemens Healthcare Private Limited
    • 14.5.2. bioMerieux SA
    • 14.5.3. Bio-rad Laboratories
    • 14.5.4. Beckman Coulter, Inc.
    • 14.5.5. F. Hoffmann-la Roche
    • 14.5.6. Inova Diagnostics, Inc.
    • 14.5.7. Myriad Genetics, Inc.
    • 14.5.8. Thermo Fisher Scientific
    • 14.5.9. Trinity Biotech Plc.
    • 14.5.10. Hemagen Diagnostics, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer